“…The rationale for applying SRT technique in RCC in extracranial metastatic lesions was the former good results using gamma-knife radiosurgery for brain metastases in RCC [9] and data indicating that selected patients benefit from surgical resection of singular metastases.…”
Section: Discussionmentioning
confidence: 99%
“…An important part in the methodology of SRT is to use CT for direct geometrical verification of the target position in the stereotactic system, instead of indirect verification of bony landmarks by portal imaging [9]. Thus, a new CT examination was done shortly before the first treatment to verify reproducibility.…”
Section: Geometrical Verificationmentioning
confidence: 99%
“…In several clinical studies however, brain metastases treated with gamma-knife radiosurgery have yielded a local control rate of 90% and survival times similar to those achieved by surgery Correspondence: Dr. Peter Wersäll, Dept of Gen Oncol, Radiumhemmet, Karolinska University Hospital, 17176 Stockholm, Sweden. E-mail: peter.Wersall@ karolinska.se [8,9]. Recently, the application of a similar radiation technique to extracranially located tumors has been made possible by the development of a stereotactic methodology for body targets enabling accurate localization of the tumor and optimal treatment with an accelerator [10,11].…”
“…The rationale for applying SRT technique in RCC in extracranial metastatic lesions was the former good results using gamma-knife radiosurgery for brain metastases in RCC [9] and data indicating that selected patients benefit from surgical resection of singular metastases.…”
Section: Discussionmentioning
confidence: 99%
“…An important part in the methodology of SRT is to use CT for direct geometrical verification of the target position in the stereotactic system, instead of indirect verification of bony landmarks by portal imaging [9]. Thus, a new CT examination was done shortly before the first treatment to verify reproducibility.…”
Section: Geometrical Verificationmentioning
confidence: 99%
“…In several clinical studies however, brain metastases treated with gamma-knife radiosurgery have yielded a local control rate of 90% and survival times similar to those achieved by surgery Correspondence: Dr. Peter Wersäll, Dept of Gen Oncol, Radiumhemmet, Karolinska University Hospital, 17176 Stockholm, Sweden. E-mail: peter.Wersall@ karolinska.se [8,9]. Recently, the application of a similar radiation technique to extracranially located tumors has been made possible by the development of a stereotactic methodology for body targets enabling accurate localization of the tumor and optimal treatment with an accelerator [10,11].…”
“…Some of the reports suggest the addition of radiosurgery to standard brain radiation may generate a clinical advantage of relieving the clinical symptoms [1,[6][7][8][9]. Stereotactic radiosurgery is currently used to treat patients who are not good candidates for conventional neurosurgical procedures.…”
Treating multiple brain metastatic sites in Gamma Knife radiosurgery is not uncommon. Most metastases can be treated with few or even one single shot. Occasionally we have patients returning for retreatment for different intracranial metastatic sites at different times. Dose distribution for these metastases are prescribed locally without considering the previous dose contribution. We present a study which simultaneously calculates the dose distribution of 25 randomly placed shots distributed inside the intracranial region. The Dose Volume Histogram (DVH) is plotted to study the coverage of the tumor sites and normal tissues. We have calculated ten DVH studies and show that 50% of the brain volume receives less than 500 cGy for the maximum tumor dose of 40 Gy, and the dose gradient is extremely steep. This DVH analysis shows that the Gamma Knife radiosurgery is a good treatment modality to control the local tumors while maintaining normal brain function, even for the large number of brain metastasis treated at different times.
“…14) This method has been used in the treatment of a variety of intracranial lesions, including arteriovenous malformations, metastatic tumors, gliomas, pituitary adenomas, acoustic neurinomas, and meningiomas. 6,11,13,16,17) Experience in using radiosurgery for benign intracranial lesions is increasing. Irradiation-induced malignancy after exposure to radiosurgery is to be anticipated, but has so far been reported in only a few patients.…”
Fig. 1 T 1 -weighted magnetic resonance imagesshowing a mass lesion in the right frontoparietal parasagittal region, and with contrast medium showing a homogeneously enhanced lesion attached to the falx with so-called dural tail sign.
AbstractA 56-year-old woman presented with an intracranial osteosarcoma at the site of previous radiosurgery, manifesting as sudden onset of headache and left hemiparesis with aphasia. She had a previous history of stereotactic radiosurgery for an intracranial tumor under a diagnosis of falx meningioma. Computed tomography showed intratumoral and peritumoral hemorrhage at the right parietofrontal region. Gross total resection of the tumor with hematoma was performed. The histological diagnosis was osteosarcoma. Sarcomatous change is a rare complication of radiotherapy. This case illustrates that osteosarcoma may develop years after radiosurgery for benign brain neoplasm.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.